Lataa...

Strategies to Inhibit Myc and Their Clinical Applicability

Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance. Myc is recognized as a “most wanted” target for cancer therapy, but has for many years been considered undruggable, mainly due to its...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Cell Dev Biol
Päätekijät: Whitfield, Jonathan R., Beaulieu, Marie-Eve, Soucek, Laura
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5322154/
https://ncbi.nlm.nih.gov/pubmed/28280720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2017.00010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!